Research & Evidence

Trial design, systematic reviews, medical statistics, and guideline updates.

  • 4 Tracked terms
  • Last 30 days Feed window

What this topic collects on

An article joins this feed when it matches these terms. Each one is also a search of its own.

Latest in Research & Evidence


pharmabiz.com > NewsDetails.aspx

Flow Neuroscience launches FL-100 in US; first US FDA-approved at-home tDCS treatment for depression

1+ day, 9+ hour ago   (84+ words) Malmö, Sweden Saturday, September 19, 2026, 16:00 Hrs [IST] Flow Neuroscienc... Flow Neuroscience launches FL-100 in US; first US FDA-approved at-home tDCS treatment for depression Flow Neuroscience, a global company developing new generation of electronic medicine for mental health, announced that FL-100 is…...


freep.com > story > news > politics > 09/18/2026 > pediatrician-say-donalds-wrong-on-measles-and-immigrants > 91614847007

Pediatricians, Dems denounce Donalds' comments tying measles to immigrants

2+ day, 16+ hour ago   (1126+ words) Florida pediatrician Dr. Lawrence Bergman says misinformation on vaccines perpetrated by powerful officials in federal and state government already means some of his tiny patients are going unprotected from diseases, like measles, that could kill them. "As a parent of…...


aol.com > articles > 3-old-boy-cancer-disappears-212017000.html

3-Year-Old Boy’s Cancer Disappears After He Gets Experimental Immunotherapy - AOL

3+ day, 3+ hour ago   (389+ words) An experimental treatment may have just given a 3-year-old boy with advanced liver cancer a new lease on life. Doctors at the Baylor College of Medicine in Texas and others detailed the near-miraculous turn of events in a report earlier…...


finance.yahoo.com > healthcare > articles > major-depressive-disorder-clinical-trial-170000001.html

Major Depressive Disorder Clinical Trial Pipeline Boom as 75+ Companies are in the Race for Better Treatments | DelveInsight

3+ day, 12+ hour ago   (448+ words) New York, USA, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Major Depressive Disorder Clinical Trial Pipeline Boom as 75+ Companies are in the Race for Better Treatments | DelveInsight DelveInsight's major depressive disorder pipeline report depicts a robust space with 75+ active players working to develop 75+ pipeline…...


2minutemedicine.com > daraxonrasib-extends-survival-in-metastatic-pancreatic-cancer

Daraxonrasib extends survival in metastatic pancreatic cancer

3+ day, 1+ hour ago   (75+ words) 2. In the randomized RASolute 302 trial, daraxonrasib extended median overall survival from 6.7 to 13.2 months and median progression-free survival from 3.6 to 7.2 months compared with standard chemotherapy. Monthly plan selected: $4.99 /month. 5-day free trial · cancel anytime Then $4.99/month. Manage renewal in your account....


forbes.com > councils > forbesbusinesscouncil > 09/04/2026 > beyond-the-system-of-record-why-modern-clinical-trials-need-a-system-of-execution

Beyond The System Of Record: Why Modern Clinical Trials Need A System Of Execution

2+ week, 1+ day ago   (605+ words) Avik Pal, Founder and CEO of CliniOps, a technology and data company with multiple patents to digitize global clinical trials. For more than two decades, clinical trial technology has been built around one central idea: Document what happened. Systems such…...


markets.businessinsider.com > news > currencies > flow-neuroscience-launches-fl-100-in-the-us-the-first-fda-approved-at-home-tdcs-treatment-for-depression-1036551432

Flow Neuroscience launches FL-100 in the US, the first FDA-approved at-home tDCS treatment for depression

4+ day, 11+ hour ago   (776+ words) Malmö, Sweden, September 16th, 2026, FinanceWire Prescription-only treatment gives clinicians a new way to treat eligible adults with moderate to severe major depressive disorder at home, either as a standalone treatment or alongside medication Flow Neuroscience today announced that FL-100 is now…...


freedom959.net > 09/16/2026 > longeveron-explores-strategic-options-after-therapy-fails-mid-stage-trial-for-infant-heart-condition

Longeveron explores strategic options after therapy fails mid-stage trial for infant heart condition

3+ day, 20+ hour ago   (258+ words) Sept 17 (Reuters) – Longeveron on Wednesday said it would explore strategic options after its experimental stem cell therapy failed to meet the main goal ​of a mid-stage trial for a rare ‌infant heart condition. Shares of the company, which have gained 32% so…...


finance.yahoo.com > healthcare > articles > upright-science-brings-together-expert-110000704.html

UpRight Science Brings Together Expert Advisory Board to Advance Balance as an Essential Health Measure

4+ day, 14+ hour ago   (215+ words) WEST PALM BEACH, Fla., Sept. 16, 2026 /PRNewswire/ -- With Falls Prevention Awareness Week approaching Sept. 21–25, UpRight Science today announced the advisory board supporting its work to establish balance as an essential measure of health and expand the usage of its FDA-cleared balance…...


blackdoctor.com > black-pediatric-eye-disease-clinical-trials

Black Kids Are Missing From Pediatric Eye Disease Clinical Trials - BlackDoctor - Where Culture Meets Care

4+ day, 3+ hour ago   (376+ words) These conditions can significantly affect a child’s development, impacting not only vision but also learning, social interactions, and overall quality of life. Early detection and intervention are critical, as many of these diseases can lead to long-term visual impairment if…...